BioNTech is developing novel Antibody-Drug Conjugates (ADCs) and other targeted therapeutics for the targeted treatment of cancer with the goal of maximizing efficacy and minimizing toxic effects to patients. To achieve this goal ADCs and/or degraders will be prepared, evaluated in a battery of in vitro and in vivo assays, then based on results, improved therapeutics will be developed. As a Chemistry Scientist in Global ADC Innovation Unit, you will help design and synthesize the payloads, linkers, and linker-payloads required to generate next generation ADCs. You may also be involved in the conjugation step, attaching linker-payloads to various antibodies. You will work closely with team members who have diverse backgrounds in Biology, Pharmacology and other disciplines. You will also prepare presentations for the team, and possibly for upper management, including progress updates and proposals for linker-payload improvements.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Mid Level
Education Level
Ph.D. or professional degree
Number of Employees
5,001-10,000 employees